These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11157712)

  • 1. High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease.
    Sdringola S; Patel D; Gould KL
    Circulation; 2001 Jan; 103(4):496-501. PubMed ID: 11157712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.
    Gould KL; Nakagawa Y; Nakagawa K; Sdringola S; Hess MJ; Haynie M; Parker N; Mullani N; Kirkeeide R
    Circulation; 2000 Apr; 101(16):1931-9. PubMed ID: 10779459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.
    Gould KL; Ornish D; Scherwitz L; Brown S; Edens RP; Hess MJ; Mullani N; Bolomey L; Dobbs F; Armstrong WT
    JAMA; 1995 Sep; 274(11):894-901. PubMed ID: 7674504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects.
    Johnson NP; Gould KL
    J Nucl Med; 2005 Sep; 46(9):1427-37. PubMed ID: 16157524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.
    Gould KL; Martucci JP; Goldberg DI; Hess MJ; Edens RP; Latifi R; Dudrick SJ
    Circulation; 1994 Apr; 89(4):1530-8. PubMed ID: 8149518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.
    Dayanikli F; Grambow D; Muzik O; Mosca L; Rubenfire M; Schwaiger M
    Circulation; 1994 Aug; 90(2):808-17. PubMed ID: 8044952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions.
    Loghin C; Sdringola S; Gould KL
    J Nucl Med; 2004 Jun; 45(6):1029-39. PubMed ID: 15181138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal longitudinal, base-to-apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risk factors.
    Hernandez-Pampaloni M; Keng FY; Kudo T; Sayre JS; Schelbert HR
    Circulation; 2001 Jul; 104(5):527-32. PubMed ID: 11479248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of relative myocardial perfusion reserve for evaluating stenosis severity in patients with single-vessel coronary artery disease using.
    Tamura T; Fujiwara M; Yoshida K; Nakagawa K; Watanabe S; Odaka K; Satoh M; Miyamoto K; Masuda Y
    Jpn Circ J; 2001 Jan; 65(1):23-7. PubMed ID: 11153817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
    De Lorenzo A; Lima RS; Siqueira-Filho AG; Pantoja MR
    Am J Cardiol; 2002 Oct; 90(8):827-32. PubMed ID: 12372568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].
    vom Dahl J
    Herz; 1997 Feb; 22(1):1-15. PubMed ID: 9173038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease.
    Sdringola S; Gould KL; Zamarka LG; McLain R; Garner J
    Am Heart J; 2008 Feb; 155(2):245-53. PubMed ID: 18215593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability.
    Kitkungvan D; Johnson NP; Roby AE; Patel MB; Kirkeeide R; Gould KL
    JACC Cardiovasc Imaging; 2017 May; 10(5):565-577. PubMed ID: 28017383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging.
    Demer LL; Gould KL; Goldstein RA; Kirkeeide RL
    J Nucl Med; 1990 Mar; 31(3):259-70. PubMed ID: 2307996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
    Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
    J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease.
    Maaniitty T; Stenström I; Bax JJ; Uusitalo V; Ukkonen H; Kajander S; Mäki M; Saraste A; Knuuti J
    JACC Cardiovasc Imaging; 2017 Nov; 10(11):1361-1370. PubMed ID: 28528146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessing myocardial perfusion with positron emission tomography].
    vom Dahl J
    Z Kardiol; 2001 Nov; 90(11):835-47. PubMed ID: 11771451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of perfusion defects on dipyridamole thallium cardiac SPECT in patients with left bundle branch block.
    Ali M; Mallick NH; Abid AR; Haq S; Ayub M
    J Ayub Med Coll Abbottabad; 2007; 19(4):21-5. PubMed ID: 18693590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis.
    Demirkol MO; Yaymaci B; Debeş H; Başaran Y; Turan F
    Cardiology; 2002; 97(1):37-42. PubMed ID: 11893828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.
    Sella EM; Sato EI; Leite WA; Oliveira Filho JA; Barbieri A
    Ann Rheum Dis; 2003 Nov; 62(11):1066-70. PubMed ID: 14583569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.